Pharmaceutical giant Novo Nordisk says data related to clinical trial participants was stolen as part of a cyberattack.
The affected patient data was pseudonymized and not directly linked to names or other direct identifiers, the company said.
The maker of the Wegovy weight-loss drug said the affected data types include patient ID, information on trial participation, gender, year of birth, biomarkers, health/immunogenicity data, and lifestyle factors including smoking status, alcohol use, and BMI.
Read more…
Source: The Register
Sign up for the Cyber Security Review Newsletter
The latest cyber security news and insights delivered right to your inbox
Related:
- 11 Gigabytes of Sensitive Data Belonging to US DoD Staff Exposed
January 5, 2017
Personal details of doctors who are deployed in the United States Special Operations Command (USSOCOM or SOCOM) have been exposed due to a security vulnerability discovered in a server operated by health services contractor Potomac Healthcare Solutions. MacKeeper Security Researcher Chris Vickery discovered in late December that Potomac, which provides healthcare workers to the government through ...